VeriMomergosterol endoperoxide est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS or CIR safety assessment, and no published reproductive or developmental toxicity studies for ergosterol endoperoxide were found. PubChem lists the substance and chemical suppliers but gives no reproductive classification, and multiple peer‑reviewed papers report anticancer/ROS activity rather than reproductive endpoints, so hazard and mechanism scores default to 0. Topical exposure is scored as low but measurable (e=1) because the compound is a lipophilic steroidal peroxide (PubChem) and has been studied for bioactivity after cellular exposure (PubMed). Sources: PubChem entry; representative PubMed studies; ECHA substance information.
Related ingredients
Frequently asked questions
- ergosterol endoperoxide est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS or CIR safety assessment, and no published reproductive or developmental toxicity studies for ergosterol endoperoxide were found. PubChem lists the substance and chemical suppliers but gives no reproductive classification, and multiple peer‑reviewed papers report anticancer/ROS activity rather than reproductive endpoints, so hazard and mechanism scores default to 0. Topical exposure is scored as low but measurable (e=1) because the compound is a lipophilic steroidal peroxide (PubChem) and has been studied for bioactivity after cellular exposure (PubMed). Sources: PubChem entry; representative PubMed studies; ECHA substance information.
- ergosterol endoperoxide est-il sûr pendant l'allaitement ?
- No data on lactation transfer or breastmilk exposure. In absence of reproductive or lactation studies and with no regulatory reproductive flags, hazard and mechanism are 0. Topical exposure scored low but measurable (e=1) for the same reasons as pregnancy (lipophilic steroidal structure; no data to indicate negligible dermal uptake).
- ergosterol endoperoxide est-il sûr pour la peau de bébé ?
- No infant-specific safety or dermal absorption studies were located. By the scoring rules, if an ingredient has measurable dermal absorption in adults (e=1) the infant exposure is increased by +1 because of immature barrier and higher surface‑area‑to‑weight, giving e=2. No infant reproductive/adverse‑development data were found, so h and m remain 0.
- Comment VeriMom évalue-t-il ergosterol endoperoxide ?
- VeriMom évalue ergosterol endoperoxide à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ergosterol endoperoxide pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ergosterol endoperoxide basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.